This inventor holds 5 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Ucb Biopharma Sprl, Ucbbiopharma Srl. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2026
Title: Discovering the Innovations of Prafulkumar Tulshibhai Chovatia
Introduction
Prafulkumar Tulshibhai Chovatia is an innovative inventor based in Abingdon, GB. He has made significant contributions to the pharmaceutical field with a total of three patents to his name. His work primarily focuses on the modulation of tumor necrosis factor (TNF) activity, which has important implications for various medical conditions.
Latest Patents
Among his latest patents, Chovatia has developed substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines. These compounds serve as modulators of tumor necrosis factor activity, offering potential benefits in treating and preventing a range of ailments. These include autoimmune and inflammatory disorders, neurological and neurodegenerative disorders, pain and nociceptive disorders, cardiovascular disorders, metabolic disorders, ocular disorders, and oncological disorders.
His other notable patent involves fused tricyclic imidazole derivatives that are also designed as modulators of TNF activity. Specifically, dihydro-1H-cyclopenta[4,5]imidazo[1,2-a]pyridine derivatives and their analogues show promise in addressing similar health issues.
Career Highlights
Currently, Chovatia is employed at UCB Biopharma Sprl, a well-regarded company in the biopharmaceutical industry. His innovative research has the potential to contribute significantly to the advancement of treatments for complex diseases.
Collaborations
Throughout his career, Chovatia has collaborated with talented professionals in his field, including Gareth Neil Brace and Boris Kroeplien. These partnerships have likely fostered an environment of creativity and innovation, essential for breakthrough discoveries in medicine.
Conclusion
Prafulkumar Tulshibhai Chovatia stands out as a prominent inventor in the pharmaceutical sector, with a focus on developing novel compounds to modulate TNF activity. His patents signify important advancements in the treatment of various human ailments, showcasing the impact of his work at UCB Biopharma Sprl. As he continues his research, further innovations from Chovatia could lead to more effective therapies and improved patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile